ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733340 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733340; 2) Community: the network communities that were significantly associated with the response to NSC 733340; 3) Molecule: the relationships between components within communities and NSC 733340; 4) MDR: the compounds that were significantly associated with the NSC 733340.

NSC Compound Enrichment Correlation
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0273093708703115 -0.23534864
NSC 603553 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-methoxy phenyl)-, hydrochloride 0.0273093708703115 0.0498637
NSC 610458 Camptothecin Derivative 0.0273093708703115 -0.053718776
NSC 639186 Raltitrexed 0.0273093708703115 -0.11532803
NSC 666220 Null 0.0273093708703115 0.26303885
NSC 681635 Camptothecin Derivative 0.0273093708703115 -0.022383989
NSC 683414 Null 0.0273093708703115 -0.055211952
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0273093708703115 0.085359541
NSC 697189 Null 0.0273093708703115 -0.014710679
NSC 701638 Null 0.0273093708703115 -0.025736614
Total:23  Current:12    [First] [Prev] [Next] [Last]